Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells

Xinhui Zhou(Guangxi Academy of Agricultural Science), Changxian Shen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Scientific Reports
May 2, 2017
10.1038/s41598-017-01729-w
Cited by 47

Related Papers

Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer
|Nature Communications|2021|43
P53 suppresses ribonucleotide reductase via inhibiting mTORC1
|Oncotarget|2017|38
Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer
|Scientific Reports|2020|22
Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast
|Nature Communications|2021|21